The trial showed that tirzepatide achieved roughly 20% weight loss (about 50 pounds) versus 14% weight loss (33 pounds) with semaglutide. This significant difference prompted analysts to declare tirzepatide the winner. As a result, clinicians are updating treatment algorithms and patients on semaglutide are asking about switching
CagriSema combines semaglutide with cagrilintide, an amylin analog, showing 20.4% weight loss in recent Phase 3 trials
The R subjects exhibited significantly reduced BMI, waist circumference (WC), RHI, 1hPG, HbA1c, INS, HOMA, m-ALB, HNE and ROS, but increased HDL (Table 2)
If youre not sure where to start or want guidance tailored to your specific medication and health goals, a registered dietitian can help you build a plan that fits
10 Targeting these TAS2Rs with bitter compounds targeting extra-oral bitter taste receptors could be a strategy to influence gastrointestinal motility, and potentially impact hunger signals, similar to the use of pharmaceutical GLP-1 agonists
36 , 130143.e135 (2024)